Astera Labs, Inc.

Worth knowing

• Profit looks boosted by one-off gains. Reported profit is 1.3× operating cash profit (EBITDA), lifted by income outside the core business.Reported profit is 1.3× operating cash profit, lifted by income outside the core business.

  Astera Labs's reported profit is 1.3× its operating cash profit (EBITDA), which is unusual: normally it's the other way round. Income outside the core business, such as interest on a large cash pile, gains on investments or asset sales, or tax items, has lifted net income, so its earnings-based valuation may look cheaper than the business alone justifies.Astera Labs's reported profit is 1.3× its operating cash profit, which is unusual: normally it's the other way round. Income outside the core business, such as interest on a large cash pile, gains on investments or asset sales, or tax items, has lifted net income, so its earnings-based valuation may look cheaper than the business alone justifies.

• Stock pay outran buybacks. Stock-based pay expense $405M vs $1M spent repurchasing shares over the 3 fiscal years to 2025.

  Over three fiscal years Astera Labs recorded $405M of stock-based pay expense and spent $1M repurchasing shares (repurchases can include shares withheld to cover employees' taxes). Repurchases were smaller than the stock pay, so they did little to offset new employee shares.Over three fiscal years Astera Labs recorded $405M of stock-based pay expense and spent $1M repurchasing shares. Repurchases were smaller than the stock pay, so they did little to offset new employee shares.

• Stock-based pay is a large cost. Stock pay was 19% of revenue in 2025.

  Astera Labs paid employees $160M in stock in 2025, 19% of its $853M revenue. It doesn't use cash, so it flatters cash flow, but it is a real cost to shareholders through dilution.

• Operating margin at a 4-year high. 20% in 2025, the best of the last 4 years.

  Astera Labs kept 20% of revenue as operating profit in 2025, its highest in the 4 years of filings we have.